SKI Market

A+| A| A-|

Indian Indices

Sensex

74,243.34 -116.67
( -0.16%)

Global Indices

Nasdaq

51,098.17 -484.76
(-0.94%)

Dow Jones

7,440.28 -165.03
(-2.17%)

Hang Seng

66,711.59 -759.10
(-1.13%)

Nikkei 225

10,374.30 13.98
(0.13%)

Forex

USD-INR

95.73 0.01
(0.01%)

EUR-INR

111.21 0.07
(0.06%)

GBP-INR

128.58 -0.06
(-0.05%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Sandu Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524703

INE751D01014

36.3372594

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

23.22

41.06

EPS(TTM)

Face Value()

Div & Yield %

1.83

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	67.19	67.28	65.35	65.50	58.76	48.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	67.19	67.28	65.35	65.50	58.76	48.37
Other Income	0.17	0.42	0.33	0.08	0.19	0.45
Stock Adjustments	1.20	-1.63	3.08	0.45	-3.39	1.03
Total Income	68.56	66.07	68.76	66.03	55.56	49.85
EXPENDITURE :
Raw Materials	33.30	30.94	34.27	36.20	31.11	26.15
Power & Fuel Cost	0.41	0.41	0.39	0.34	0.33	0.33
Employee Cost	10.92	10.07	11.10	8.91	8.02	6.85
Other Manufacturing Expenses	6.24	6.35	6.19	5.98	5.21	4.22
Selling & Administrative Expenses	14.51	15.24	13.75	11.45	8.31	10.28
Miscellaneous Expenses	0.25	0.34	0.25	0.19	0.24	0.12
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	65.63	63.35	65.94	63.08	53.21	47.95
Operating Profit	2.93	2.72	2.82	2.96	2.35	1.90
Interest	0.10	0.06	0.08	0.11	0.11	0.43
Gross Profit	2.83	2.66	2.74	2.85	2.24	1.47
Depreciation	0.67	0.58	0.52	0.53	0.56	0.55
Profit Before Tax	2.16	2.08	2.22	2.32	1.68	0.92
Tax	0.59	0.59	0.66	0.70	0.56	0.13
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.02	0.02	0.03	0.03	0.03	0.07
Reported Net Profit	1.55	1.46	1.52	1.59	1.09	0.72
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	1.55	1.46	1.52	1.59	1.09	0.72
Adjustment below Net Profit	0.02	0.02	0.00	0.00	0.00	0.00
P & L Balance brought forward	8.59	7.70	6.68	4.97	3.27	2.41
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.63	0.59	0.51	-0.11	-0.61	-0.14
P & L Balance carried down	9.52	8.59	7.70	6.68	4.97	3.27
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	8.00	8.00	0.00	7.50	5.00	0.00
Dividend Per Share(Rs)	0.80	0.80	0.00	0.75	0.50	0.00
Earnings Per Share-Unit Curr	1.60	1.51	1.58	1.80	1.38	1.02
Earnings Per Share(Adj)-Unit Curr	1.60	1.51	1.58	1.80	1.38	1.02
Book Value-Unit Curr	34.63	33.01	40.62	30.71	29.63	28.22
Book Value(Adj)-Unit Curr	34.63	33.01	40.62	30.71	29.63	28.22

74,243.34 -116.67 ( -0.16%)

51,098.17 -484.76 (-0.94%)

7,440.28 -165.03 (-2.17%)

66,711.59 -759.10 (-1.13%)

10,374.30 13.98 (0.13%)

95.73 0.01 (0.01%)

111.21 0.07 (0.06%)

128.58 -0.06 (-0.05%)

0.60 0.00 (0.01%)